News & Events

News & Events2022-04-29T14:41:55+00:00
2009, 2022

Join Avance Biosciences at Biotech Boston Sept 27-30, 2022!

September 20th, 2022|Gene & Cell Therapy Testing, News|

Ensure the Success of Your Biological Drug Development - Avance Provides Assays to Support your Biopharmaceutical Development & Manufacturing - Avance Biosciences is a world-leading CRO specializing in GLP & GMP compliant biological assay development, assay validation, and [...]

1309, 2022

Kyverna Therapeutics’ $85 million series B financing reflects significant investor confidence in the science behind cell therapies

September 13th, 2022|Gene & Cell Therapy Testing, News|

Kyverna Therapeutics, a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced it has closed an oversubscribed $85 million Series B financing round led by Northpond Ventures. Additional investors included the company’s founding [...]

3008, 2022

First allogeneic cell therapy candidate engineered to target cd19 for b-cell malignancies receives IND clearance, will proceed to clinical trials

August 30th, 2022|Gene & Cell Therapy Testing, News|

Century Therapeutics, an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, announced today that the company has been notified by the U.S. Food and Drug Administration (FDA) that the Company’s ELiPSE-1 clinical study may proceed [...]

2308, 2022

FDA approves the first gene therapy for people with beta-thalassemia who require regular red blood cell transfusions

August 23rd, 2022|Gene & Cell Therapy Testing, News|

bluebird bio has announced the the U.S. Food and Drug Administration (FDA) has approved ZYNTEGLO® (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who [...]

208, 2022

ARM and NIIMBL Release Project A-Cell to Bring Quality by Design Principles to Cell-Based Therapy Manufacturing

August 2nd, 2022|CAR-T & Other Cell Therapy Testing, Gene & Cell Therapy Testing|

Effort to address challenges to the manufacturing scale-up of cell-based therapies follows release of Project A-Gene for gene therapy in 2021 The Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing BioPharmaceuticals (NIIMBL) today released Project [...]

Load More Posts